Flunitrazolam 0.25 mg Pellets – Precision Dosed Benzodiazepine Analogue for Scientific Research

Introduction to Flunitrazolam

Flunitrazolam is a highly potent triazolo-benzodiazepine-like compound with distinct pharmacological properties. These 0.25 mg pellets were specifically developed for controlled scientific research into GABAergic neurotransmission and related neurological processes.

Critical Quality Characteristics

• Nákvæm skömmtun : Each pellet contains exactly 0.25 mg Flunitrazolam (±2% variation)
• Advanced pharmaceutical formulation : Microcrystalline cellulose matrix for optimal bioavailability
• Stöðug samsetning : Protected against photodegradation and moisture absorption
• Rigorous quality control : Each production batch is subject to:
  • HPLC analysis (purity ≥98%)
  • Mass spectrometry confirmation
  • Uniformity control of weight and diameter

Pharmacodynamic Properties

Flunitrazolam exhibits characteristic properties:

• Extremely high potency : Active in nanomolar concentrations
• Selective GABA-A receptor modulation :
  • Strong binding to α1, α2, and α3 subunit-containing receptors
  • Amplification of chloride ion current
• Pronounced pharmacological effects :
  • Anxiolytic activity
  • Sedative effect
  • Muscle-relaxing properties. Kaupa íbógain HCL

Scientific Research Applications

Particularly valuable for:

1. Neuropharmacological studies :
   • GABAergic signal transduction mechanisms
   • Receptor subtype specificity
   • Allosteric modulation processes
2. Samanburðarlyfjafræði :
   • Potency comparison with classical benzodiazepines
   • Structural-activity relationships within triazolobenzodiazepines
3. Behavioral Neuroscience :
   • Anxiety-related behavioral paradigms
   • Sleep-wake cycle research
   • Seizure inhibition studies

Tæknilegar upplýsingar

• Líkamleg einkenni :
  • Diameter: 2.0mm ± 0.1mm
  • Weight: 8 mg ± 0.5 mg per pellet
  • Litur: Hreint hvítt
  • Leysni: >5 mg/ml í etanóli (96%)
• Stability parameters :
  • Shelf life: 36 months at 15-25°C (in original packaging)
  • Light sensitivity: Photodegradation <1% per year (stored in the dark)
  • Moisture content: <0.5% (Karl Fischer method)

Research dosage

Aðeins til vísindalegrar viðmiðunar:

• Rannsóknir in vitro : 1-100 nM concentrations
• Preclinical evaluations : 0.01-0.1 mg/kg body weight
• Atferlisrannsóknir : 0.02-0.2 mg/kg (model-dependent). 1V-LSD 150 MCG þynnur

Safety and Storage Protocols

• Stability guarantee : Under controlled conditions
• Compatibility studies : Verified with:
  • Physiological saline solution (0.9% NaCl)
  • Phosphate buffer (PBS, pH 7.4)
  • Dimethyl sulfoxide (DMSO)
• Geymslukröfur :
  • Primary packaging: Light-blocking glass
  • Secondary packaging: Oxygen absorbing material
  • Temperature range: 15-25°C

Quality documentation

With every order you will receive:

1. Analytical Certificate of Analysis including:

• HPLC chromatogram
• Mass spectrum
• Purity percentage
• Heavy metal analysis

2. Extended Safety Data Sheet according to GHS standard
3. Technical Support Documentation :

• Solubility data
• Stöðugleikaprófíll
• Proposed research protocols

These pellets are intended solely for scientific research by qualified professionals in controlled laboratory environments. Not intended for diagnostic or therapeutic use. 1cP-LSD 150 MCG listabletti